Mylan Still Mulling Revance's Botox Biosimilar

Firms Are Still In Discussions Despite Passing 30 April Deadline

 
• By David Wallace
Girl_Botox_Injection
Revance is still waiting for a decision from Mylan despite passing a key date • Source: Shutterstock

More from Biosimilars

More from Products